Vol. 128, No. 2, 1985
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
April 30, 1985
Pages 650-656
REGULATION
OF SYNTHESIS AND NADPH-CYTOCHROME
ACTIVITY OF BOVINE ADRENOCORTICAL P-450 REDUCTASE BY ACTH
Albert Dee*, Grace Bettie Sue Masters** *
Department **
Received
of Biochemistry, Department
February
Carlson”, Cydnie Smith* and Michael R. Waterman*
University Dallas, TX
of Biochemistry, Milwaukee,
of Texas 75235
Health
Medical College WI 53226
Science
Center
of Wisconsin
18, 1985
Primary, monolayer cultures of bovine adrenocortical cells have been utilized to demonstrate that ACTH regulates the synthesis .and thus the activity of NADPH-cytochrome P-450 reductase. The temporal pattern of induction correlates well with that previously reported for cytochromes and P-450c2,, microsomal steroid hydroxylases serviced by P-450 23@e Results of fi vitro translation studies suggest that ACTH . regulates P-450 reductase synms at the transcriptional level and show that the adrenocortical enzyme is synthesized as the mature form. The action of ACTH to induce P-450 reductase synthesis in the adrenal cortex can be mimicked by dibutyryl CAMP, but not by. phenobarbital which induces P-450 reductase synthesis in liver. 0 1985 Academic Press, Inc.
The both
steroidogenic
mitochondrial
mitochondrial
chain
adrenodoxin are
and
steroid
transport
reduced
is
likely
as liver,
lung
tissues
such
steroid
hydroxylases species.
P-450c2,,
purified
arid
their
or liver
microsomal
identical and
localized
of
activities P-450
by
The
to
in the
is
a
respectively).
reductase
be
reconstituted (6-9).
650
form of
these using
The electron and
hydroxylases
reductase
(3-51,
found cortex
reticulum,
contain
an
steroid
adrenal
distinct
via
reductase
endoplasmic
Both
$1.50
0 1985 by Academic Press. Inc. of reproduction in any form reserved.
P-450
involve
(flavoprotein)
P-450
microsomes
which
can
the
testis
reactions.
NADPH
microsomal
In the
kidney.
and
reductase
NADPH-cytochrome
adrenocortical
each
( P-450, Ta and
Cowright All rights
are
Bovine
CZl-hydroxylase,
0006-291X/85
via
reduced
(1,21.
ovary
hydroxylation
adrenodoxin
protein)
NADPH
which
are
of
cortex,
steroid
hydroxylases
consisting
by
in adrenal
microsomal
(iron-sulfur
flavoprotein
the
pathways
in one
a
other or
two
depending
on
17a-hydroxylase of
cytochrome enzymes
either
have
and P-450 been
adrenocortical
BIOCHEMICAL
Vol. 128, No. 2, 1985 Steroidogenesis (ACTH),
which The
(10). capacity
has both
chronic
and
increased
involves
either
newly
enzyme
to be
(11.13).
In the
present
whether
translation
of RNA
level;
whether
enzyme
cyclic
to
increased
synthesis this
suggesting
the
adrenal
P-450
in a manner
to that
and
other
related
whether
can
regulation
cortex.
RNA
can be
cells,
synthesized
ACTH of
the
from
newly
have
CAMP
been
(such
P-450,7a
ACTH
[and
be
detected at the
to increased
amounts
whether
phenobarbital
is chronically the
which
results regulated
steroidogenic
to
immunoisolating
of
occurs
The
for
leads
thus
as and
CAMP)
NADPH-cytochrome
synthesis
and
pathway.
ACTH
cytochromes
adrenocortical
leads
described
and
analogs of
examined
with
the
thus,
steroidogenic
P-45OC2,,
actions
pathway
of this
isolating
chronic
the
reductase
and
by
and,
reductase;
NADPH-cytochrome similar
or
in
synthesis
cells
protein
synthesis
that
of optimal
immunoisolating
of
steroidogenic
of components
cellular
AMP
increase
on the
P-450,,a
and
we have
P-450 in
acute
by adrenocorticotropin
adrenocortical
and
by
increased
NADPH-cytochrome this
the
study
the
reductase;
of synthesis
vitro,
RESEARCH COMMUNICATIONS
maintenance
hydroxylase
-in
lead
regulates
for
total
steroid
mediated
P-450C2,
is required
radiolabeling
Both
cAh!P)
effects
cytochromes
RNA
dibutyryl
chronic
of both
(11,12).
found
is regulated
bovine
by
the
and
cortex
of cultured
synthesized
translating
acute
regulation
synthesis
detected
adrenal
effect
stimulation
Thus,
also
in the
AND BIOPHYSICAL
P-450 by
--in
vitro
transcriptional and
activity can
indicate --in vivo cytochromes
that by
of
induce the ACTH P-450
enzymes.
METHODS
AND
MATERIALS
Primary monolayer cultures of bovine adrenocortical cells were prepared as previously described (14) and grown to confluency. The confluent monolayers were removed from antibiotic-containing medium and 24 hours later an experiment was begun. Cell cultures were maintained in the presence or absence of ACTH (1 PM). At various times following35initiation of ACTH treatment, total cellular protein was radiolabeled with S-methionine (New England Nuclear) as previously described (14). From other cultures total cellular RNA was isolated and translated in a reticulocyte lysate cell-free system (14). Newly synthesized NADPH-cytochrome P-450 reductase was immunoisolated from total newly synthesized proteins obtained by either procedure. Purified pig liver NADPH-cytochrome P-450 reductase and the IgG fraction raised against this protein were prepared as described previously 651
Vol. 128, No. 2, 1985
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
NADPH-cytochrome c reductase were (15). activities determined in post-mitochondrial supernatani fractions prepared from cultured cells (16) using standard assay procedures (171. Protein concentrations were measured according to Bradford (18). Electrotransfer of cellular proteins and immunoblot analysis were performed as previously described (11,19). Responsiveness of cell cultures to ACTH was determined by cortisol measurements using radioimmunoassay (20).
RESULTS The
ability
P-450
reductase
Fig.
1.
In
of the
to recognize lane
immunoisolated enzyme, liver
1 it
by
having
this
weight
enzyme
to compete
in
of ACTH
as does
the
two
microsomal
preliminary
evidence
the
the
protein
that
protein liver
of 100 I.L~ purified
pig
2).
purified
Thus,
and
the
was
concluded
RNA
from
based
ability
on
the
of
purified
that
anti-pig
to study
the
bovine
size
RNA
as
the
occurs
which
isolated
treated
with 2-fold.
mature,
ACTH, Also, purified 652
rate
24 hours
of synthesis
increase
is
in synthesis
P-45O,7,
(111,
To
obtain
and
services. might
adrenocortical system. P-450
reductase,
is maximal
at 24 hours.
the
synthesized
enzyme.
in
(12) it
newly
shown
at
translation
NADPH-cytochrome
is
12 and
in synthesis
from
P-450
approximately
P-450C21
increase
ACTH
the the
optimizes
the
was
to between
Thus,
cells.
in an --in vitro
synthesized
is approximately
response
hydroxylases
as to whether
NADPH-cytochrome
At 24 hours,
reductase
steroid
cells
of
in
of cytochromes
synthesis
newly
cells
in control
synthesis
in transcription,
same
in
pig
be utilized
synthesis
in synthesis
P-450
time
increase
it
could
treatment.
that
NADPH-cytochrome
using
protein
the
increase
2 times
to direct
of
adrenocortical
maximal
approximately
seen
the
Addition (lane
is illustrated
radiolabeled
with
of 78,000.
reductase
NADPH-cytochrome
predominant
immunoisolation,
pattern
initiation
increase
the
immunoisolation
this
liver
enzyme
co-electrophoreses
P-450
bovine
The
following
that
pig
adrenocortical
immunoisolated
with
temporal
reductase 2.
seen
against
enzyme.
The
Fig.
bovine
weight
the
NADPH-cytochrome
adrenocortical
the
this
of
DISCUSSION
prepared
antibody
inhibits
molecular
of
is
a molecular
reductase
liver
antibody
AND
This
agrees
the
same
involve
cells
and
an used
In Fig.
3 it is
determined Again,
the
reductase with
earlier
is
Vol.
128,
0
'1
No. 2, 1985
BIOCHEMICAL
0
2
2
AND
BIOPHYSICAL
RESEARCH
03
1234567
12
COMMUNICATIONS
34
56
7
Immunoisolation of bovine adrenocortical NADPH-cytochrome P-450 w: re uctase using an IgG fraction raised against pig liver NADPH-cytochrome of newly synthesized, radiolabeled P-450 reductase. Lane 1, immunoisolation P-450 reductase from bovine adrenocortical cells treated with ACTH (1 i.rM) for 36 hours. Lane 2, Identical to lane 1 except immunoisolation was carried P-450 reductase which comp&es out in the presence of 100 ug pig liver against the radiolabeled enzyme. The arrow indicates the position of migration of the purified pig liver enzyme on the same gel as determined by staining with Coomassie blue. lmmunoisolation of newly synthesized bovine adrenocortical H cytochrome P-450 reductase from cells maintained for various tines in the presence or absence of ACTH. Lane 1, 0 time; Lanes 2.4 atld 6 from cells maintained for 12,24 and 36 hours, respectively, in the absence of ACTH; Lanes 3.5, and 7 from cells maintained for 12.24 and 36 hours. respectively, in ihe presence of ACTH (1uM). In all samples, immunoisolation The arrow was carried out from the same amount of total radioactivity. indicates the position of migration of purified pig liver P-450 reductase on the same gel.
!i?i!s:
lmmunoisolation of newly synthesized adrenocortical P-450 reductase directed by RNA isolated from bovine adrenocoitical cells maintained in the presence or absence of ACTH for various times. Lane 1, 0 time; Lanes 2 and 3 from cells maintained for 24 and 48 hours, respectively, in the absence of ACTH; Lanes 4-7 from cells maintained for 12,24,36 and 48 hours. resoectivelv, in the oresence of ACTH In all samples, immunoisolatidn was carried out fro& the same amount (1O.J). of total radioactivity. The arrow indicates the position of miaration of purified pig liver P-450 reductase on the same gel.
reports synthesized
indicating as
that its
mature
rat
liver
form
(21).
tJADPH-cytochrome
653
P-450
reductase
is
Vol. 128, No. 2, 1985
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
TABLE
1
NADPH-Cytochrome c t?eductase Activity in Post Mitochondrial Supernatant Fractions from Cultured Bovine Adrenocortical Cells Time
-ACTI
+ACTH
(nmollmlnlmg 12 h 24 h 36 h
48 h 60 h
-
I-resh gland
In
both
synthesis
of
2-fold
types
approximate appears the
activity
of
in
2-fold
activity
we
and
in
binding
reductase after
36
hours.
of both
FAD
seen
However,
initiation
of ACTH
FMN,
the
Table
well
activity.
this
increase
in
correlates
Perhaps and
a modest
As
parameters
24 hours
at
only
reductase.
synthesis
about
observe
P-450
increase
maximizes
synthesis
5.8 5.2
experiments,
the
to maximize
4.0 5.6 7.0
= 15.2 rrniol/mln/mg
NADPH-cytochrcme
increase
proteln)
2.4 3.4 3.1 4.2 3.3
in 1 the
with
the
an
synthesis
treatment
difference cofactors
while
is
related
required
for
to this
enzyme. It
is
interesting
approximately activity induction
On
of
the
has
cultured arld
seems
cyclic
that
reductase
the is limited
The
results
reductase
provide
further
limited
to
2 and
phenobarbital
NADPH-cytochrome this
in
lung
xenobiotic
as
determined
increase
As
effect
of
no
shown
P-450 by
the
P-450 has
(23).
phenobarbital
on
the
Figure
reductase
of this
4,
levels
analysis, enzyme.
on
to
reductase
effect in
immunoblot
level
leads
in
while Thus,
cytochrome
it
P-450
to liver. presented
in
this
is synthesized indication liver.
NADPH-cytochrome (Figs.
liver,
NADPH-cytochrome
analogs
inductive
rat
hand,
on
cells
in of
activity
no effect
AMP
that
other
adrenocortical
ACTH
note induction
reductase
phenobarbital
P-450
2-fold
a
(22).
to
that
that
form
phenobarbital
reductase this
indicate
as the mature
Furthermore, P-450
3) and
study
effect
it is
NADPH-cytochrome
in adrenocortical induction
is
regulated
is mediated 654
that
of
in adrenal by
this
that
shown
cyclic
tissue
and
enzyme
synthesis cortex
AMP
(Fig.
by
is of
ACTH 4).
In
Vol.
128,
BIOCHEMICAL
No. 2, 1985
AND
12
lmmunoblot analysis ovme adrenocortical cells Lane 1, no for 24 hours. Lane 3, dibutyryl (1 NJ; phenobarbital treatment (2 migration of purified pig liver
respect,
hydroxylases their
and
stimulating
P-450
reductase
thought
to
this
in
factors
levels
and
is
Presumably,
enzyme.
(phenobarbital)
CAMP-mediated regulate
( 10,24)
.
factors),
found
of
for
Likewise,
in
have
interesting
gene
has
one the
this
in
tissue
to
hand, other
maintenance
found
in is
the
and hand,
to
be
physiological and
thus
induce
reductase
which
examine
cells, to
is
microsomal
thought
capacity
of
granulosa
been
enzyme
the
steroid
P-450
any
the
be
the
on
ACTH
analogs
addition,
this
adrenocortical
NADPH-cytochrome
will
, on
expression
require
CAMP
In it
other
which
enzyme
found. Thus,
like
(19,25).
ubiquitous
tissues.
xenobiotics or
an
P-450 all
enzymes
hormone synthesis
be
cytochrome same
related
COMMUNICATIONS
34
responds
endogenous
optimal
follicle
enzyme
the
RESEARCH
of NADPH-cytochrome P-4SO reductase levels maintained in the presence of various effecters treatment (control); Lane 2, ACTH treatment cyclic AMP treatment (1 mM); Lane 4, mM). The arrow indicates the position of P-450 reductase.
Pi?:
this
BIOPHYSICAL
to gene
be encoding
regulated factors tissue
by (cAMP specific
gene.
ACKNOWLEDGM,ENTS
(BSM)
This work and by
was Grant
supported l-624
by from
The
USPHS grants Robert A. 655
AM Welch
28350 (MRW) Foundation.
the
and
HL30050
Vol. 128, No. 2, 1985
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
REFERENCES Suzuki, K. and Kimura, T. (1965) FEBS Lett. 19, 340-345. Omura, T., Sanders, E., Estabrook, K.K, Cooper, D.Y. and Rosenthal, 0. (1966) Arch. Biochem. Biophys. 11, 660-673. B.S.S., 3. Masters, Nelson, E. B., Schacter, B.A., Baron, J. and Isaacson, E.L. (1973) Drug Met. Disp. 1, 121-128. J.B., Nelson, t.B., Masters, B.S.S. and Bryan, C.T. (1973) 4. Harkins, Endocrinol. 92, 897-902. A. and Ichikawa, Y. (1979) Biochim. Biophys. Acta 5. Hiwatashi, -’580 44-63. 6. Nakajin, S. and Hall, P.F. (1981) J. Biol. Chem. 256, 13871-13876. M. and Hall, P.F. (1983) Bxhem. Biophys. Res. 7. Nakajin, S., Shinoda, Commun. 111, 512-517. Kominami,S., Ochi, H., Kobayashi, Y. and Takemori, S. (1980) 8. J. Biol. Chem. 255, 3386-3394. and Dus, K.M. (1982) J. Biol. Chem. %,;2696-12704. 9. Bumpus,= 10. Simpson, E.R. and Waterman, . . (1983) Can. J. Biochem. and Cell Biol. 61, 692-707. 11. Luber, M.X., Simpson, E.R., HaTI, P.F. and Waterman, M.R. (1985) 1. Biol. Chem. 260, In Press. 12. Funkenstein, B., McCarthy, J.L., Dus, K.M., Simpson, E.R. and Waterman, M.R. (1983) J. Biol. Chem. 258, 9398-9405. Boggaram, V., Waterman, M. R. (1984) 13. Simpson, E. R. and Arch. Biochem. Biophys. 231, 271-279. 14. Kramer,., Simpson, E. R. and Waterman, M. R. (1983) J. Biol. Chem. 258, 3000-3005. 15. yasukochl, Y., mita, R.T. and Masters, B.S.S. (1980) Arch. Biochem. Bio h s. 202, 491-498. Kramer R.E Funkenstein, B., Simpson, E.R. and 16. ay7.L Waterman: M.R:‘(1983) A;ch. i&hem. Biophys. 222, 590-598. 17. Masters, B.S.S., Williams, C.H. and Kamin. H, (1963) Methods in Enzvmol. 10, 565-573. 18. Bradford,x-.M. (1976) Anal. Biochem. 72, 248-254. 19. Funkenstein, B., Waterman, M.R., Masters, B.S.S. and Simpson, E.R. (1983) J. Biol. Chem. 258, 10187-10191. 20. Simpson, E.R., WatersTJ. and Williams-Smith, D.L. (1975) J. Steroid Biochem. 6, 395-400. Gonzalez,).J. and Kasper, C.B. (1980) Biochemistry 19, 1790-1796. 21. Ernster, L. and Orrenius, S. (1965) Fed. Proc. 24, 1 li-1199. 22. Litterst, C.L., Mimnaugh, E.G. and Gram, 7.E. (1977) Biochem. 23. --__ Pharmacol. 26, 749-755. KR. (1982) Xenobiotica 12 773-786. 24. Waterman, 25. Durham, C.R., Zu, H., Masters, Bx.S., Simpson, E.R. and Mendelson, C.R. (1985) Molec. Cell. Endo., In Press. 1. 2.
656